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MANIFESTATIONS OF ACUTE AND CHRONIC GRAFT-VERSUS-HOST-DIS-
EASE IN REDUCED-INTENSITY ALLOGENEIC STEM CELL TRANSPLAN-
TATION (RISCT) FOR PEDIATRIC CANCER
Baird, K.1, Fry, T.J.1, Love, C.1, Layton, P.1, Rager, A.1,2,
Cordoza-Salzman, T.1, Mackall, C.L.1, Wayne, A.S.1 1National Insti-
tutes of Health, National Cancer Institute, Pediatric Branch, Bethesda,
MD; 2Duke University School of Medicine, NC.
Background: Allogeneic stem cell transplantation (alloSCT)
plays an important role in the treatment of pediatric malignancies.
Unfortunately, its success is limited by toxicities associated with
myeloablative preparative regimens. We have piloted a reduced
intensity alloSCT (RISCT) approach intended to reduce toxicity
and to promote rapid immune recovery and enhanced Graft-Ver-
sus-Tumor (GVT) effect. The risk of increased GVT effects may
coincide with increased manifestations of GVHD. Although the
adult RISCT experience has shown increased GVHD, the pediat-
ric oncology experience is limited. Here we review the unique
manifestations of GVHD in pediatric patients undergoing RISCT
at our institution.
Methods: We piloted a RISCT regimen in 26 pediatric patients
with high-risk hematologic malignancies and sarcomas. Fludara-
bine-based induction chemotherapy was administered for disease
control and targeted CD4 count reduction. Pre-transplant condi-
tioning consisted of cyclophosphamide (1,200 mg/m2/day) and
ﬂudarabine (30 mg/m2/day) x 4 days plus melphalan (100 mg/
m2 1 dose in sarcoma pts). Grafts consisted of G-CSF mobilized
unmodiﬁed peripheral blood stem cells from 5-6/6 HLA-matched
ﬁrst-degree relatives (median CD34 dose 9.42  106/kg; median
CD3 dose 387  106/kg). Cyclosporine was used for GVHD
prophylaxis in both trials, 3 sarcoma patients also received siroli-
mus.
Results: Twenty-three of 26 recipients developed aGVHD: 18
with grade 1-2, 4 with grade 3, and 1 with grade 4. Twenty-one of
23 patients with 100 days follow-up developed cGVHD. GVHD
has been reponsive in most and 6 of 11 surviving remain on
treatment. Unique ﬁndings in this group include a high incidence
of cGVHD (91%), including high rates of bronchiolitis obliterans
and eye involvement. We have also seen recurrent GVHD ﬂares
associated with cytotoxic chemotherapy given for disease relapse.
Interestingly, we have observed rapid immune recovery despite
GVHD and the need for systemic therapy.
Conclusions: Despite a signiﬁcant percentage of recipients ex-
periencing acute and chronic GVHD, the transplant is overall well
tolerated. Both trials however were amended to reduce the inci-
dence of GVHD. Sirolimus was added as prophylaxis in sarcoma
patients and the stem cell source for those with hematologic ma-
lignancies was changed from peripheral blood to bone marrow.
With modiﬁcations aimed to control GVHD, the RISCT regimen
may allow for successful application of this approach in pediatric
cancers.
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ROLE OF RESPIRATORY VIRAL INFECTION IN THE DEVELOPMENT OF
ALLO-REACTIVE LUNG DISEASE
Versluys, B.1, Rossen, J.2, Bierings, M.1, Schuurman, R.2,
Ewijk, B. van3, Boelens, J.J.1 1UMCU/WKZ: Dept. Heamotology/
Immunology/BMT, Utrecht, Netherlands; 2UMCU: Dept. of Virology,
Utrecht, Netherlands; 3UMCU/WKZ: Dept. of Pulmonology, Utrecht,
Netherlands.
Background: In lung transplants respiratory viruses (RV) are
associated with bronchiolitis obliterans (BO) and rejection. Also in
stem cell transplantation (SCT) RV may progress to pneumonia or
might trigger immunological mediated effects on lungfunction.
We prospectively studied the clinical impact of RV in pediatric
SCT patients.
Methods: All patients with respiratory symptoms had a nasopha-
ryngeal aspirate taken, and a PCR on all common RVs was done.
The test was repeated weekly. Initial clinical symptoms were noted,
as were long term complications. Bronchiolitis obliterans (BO) and
Idiopathic pneumonia syndrome (IPS) were reagard as allo-reac-
tive lungdiseases (alloLD) and analyzed as group. A risk factor
analyses was performed using logistic regression.
Results: 73 SCTs were done from 40 matched donors and 33
mismatched donors. Median follow up was 17 (5-34) months.
Overall survival was 59%. Acute-graft versus host disease (GVHD)
 grade I occurred in 25%. Chronic-GVHD occurred in 20%. In
36 pts a RV was identiﬁed between day -7 and day30: rhino-(16),
parainﬂuenza-(3), inﬂuenza-(1), adeno- (2) and multiple viruses
(11). Three patients with otherwise unexplained typical viral symp-
toms were considered as RV positive, despite negative PCRs.
Initial clinical symptoms were usually mild allthough the virus was
not cleared for wks/mths. IPS occurred in 10 pts, at a median of 7
wks post-HCT (range 3-12) of whom 5 died. BO occurred in 7 pts,
at 16 weeks post-SCT (range 12-26): Four patients died and 1 is
awaiting lung transplantation. In the RV negative group only 1
patient developed a IPS coinciding grade IV aGVHD. In a mul-
tivariate analysis only a RV-infection was a risk factor for devel-
oping alloLD (p 0.002, OR 55, range 5-660). Contradictary,
aGvHD was associated with a lower incidence of alloLD (OR 0.05,
range 0.003-0.80; p0,034). Perhaps treatment given for aGvHD
protected for development of alloLD. The onset of aGvHD was
earlier than alloLD.
Conclusion: RV infection early after SCT is associated with
increase susceptibility for alloLD. Although the exact role of RV in
these complications should be elucidated the fact that aGvHD (and
treatment) protected for alloLD suggests allo-reactivity to play a
central role. Better isolation methods, close monitoring of pulmo-
nary function and early initiation of immunosuppressive treatment
or prolonged immuno-suppressive treatment in RV-positive pa-
tients might inﬂuence the outcome.
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REDUCED INTENSITY CONDITIONING ALLOGRAFTING INDUCES THE
GENERATION OF ANTIGEN-SPECIFIC REGULATORY T CELLS NECES-
SARY FOR GRAFT TOLERANCE
Weng, L.1, Dyson, J.2, Dazzi, F.1 1Department of Haematology, Im-
perial College, London, United Kingdom; 2Department of Immunology,
Imperial College, London, United Kingdom.
Reduced intensity conditioning (RIC) regimens have been devel-
oped to assist the establishment of host-versus-graft (HvG) toler-
ance which is required for the subsequent use of donor lymphocyte
infusions. Therefore, understanding the mechanisms of HvG tol-
erance is crucial for maximising the donor lymphocyte mediated
graft versus leukaemia (GvL) effect. To address this question we
have utilized an animal model whereby sublethally irradiated
(400cGy) female recipients were transplanted with bone marrow
(BM) cells from syngeneic male donors. Under these conditions,
donor cells engraft and HvG tolerance speciﬁc for the male HY
antigen is established. We observed a selective expansion of T cells
with a regulatory phenotype (CD4CD25FoxP3) in the pe-
ripheral blood, spleen, and bone marrow of recipient mice. Such
expansion was not antigen-dependent nor it depended on the
administration of donor hematopoietic cells. In fact, irradiation
alone or the irradiation and infusion of female BM cells were
sufﬁcient to generate similar levels of Treg expansion. However,
when we evaluated the effect of recipient chimeric spleens on
HY-speciﬁc MLR, an immunosuppressive activity was identiﬁed
which was only detectable when the mice were transplanted with
male but not female BM cells. Such activity was also observed in
vivo: the adoptive transfer of chimeric splenocytes prevented in
vivo killing of CFSE-labelled male donor cells in female hosts, and
enhanced male donor BM engraftment in suboptimally condi-
tioned (200cGy) female recipients. To conﬁrm the role of Treg in
this suppressive activity, we depleted chimeric spleen of CD4 or
CD25 cells and in both cases the suppression was abolished or
much reduced. The fundamental role of Tregs in RIC induced
tolerance was supported by the fact that administration of anti-
CD25 depleting antibodies to conditioned recipients at the time of
SCT prevents the induction of Tregs and donor-recipient chimer-
ism. Our data demonstrate that: 1. CD4CD25FoxP3 Tregs
are required for the generation of HvG tolerance after RIC al-
lografting and 2. the presence of the antigen during homeostatic
expansion induce the generation of antigen-speciﬁc Treg.
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